← Back
Data updated: Mar 29, 2026
DASH PHARMS
OncologyMetabolic
Generics
DASH PHARMS is a generic drug manufacturer focused on Oncology, Metabolic.
1987
Since
8
Drugs
-
Trials
74
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
RISPERIDONE 2025-11-04
Labeling
RISPERIDONE 2025-09-11
Labeling
RISPERIDONE 2025-09-02
RISPERIDONE 2025-09-02
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
1 drugs
Metabolic 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (5)
Company Info
- First Approval
- 1987-10-19
- Latest
- 2025-08-21
- Applications
- 11